Trial intelligence / Profile preview

Losartan in proteinuric CKD patients with lower-normal blood pressure

ChiCTR-TRC-09000462Phase 4Completed

Sponsor
Renji Hospital
Start
Jun 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of losartan in chronic kidney disease (CKD) (2 arms), sponsored by Renji Hospital. Primary endpoint: 24-hour urine protein. Started Jun 2009; status: completed.

02

Drugs

losartan
03

Conditions

chronic kidney disease (CKD)

Beyond the preview

Go deeper on ChiCTR-TRC-09000462.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-09000462.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call